Re The panel of experts developing the guidelines also looked at two other drugs for severe & critical #COVID19: ruxolitinib and tofacitinib. Given th…


Re The panel of experts developing the guidelines also looked at two other drugs for severe & critical #COVID19: ruxolitinib and tofacitinib.
Given their uncertain effects, WHO made a conditional recommendation against their use

World Health Organization (WHO): WHO recommends two new medicines for #COVID19, providing yet more options for treating the disease

https://bit.ly/3flUftt

LikedLiked 2 views